endogenous glp 1 Intestinal glucagon-like peptide-1 effects on food intake: Physiological relevance and emerging mechanisms GLP-1 Drugs and the Physiology

Studies have reported that among SCFAs, butyrate alone is responsible for gut motility, possibly via regulating serotonin, and can be used to increase propulsive gut movement, making it a suitable microbial therapeutic for patients with IBS (Vincent et al., 2018)

While 62% of users report using these medications to manage chronic conditions such as diabetes or heart disease, about a quarter are primarily focused on weight loss

However, insulin resistance and associated metabolic dysfunction can lead to release of excess free fatty acids into the bloodstream, buildup of free fatty acids and triglycerides in the liver, and bloating of hepatocytes with too much fat

MIDI was recently challenged by the National Advertising Division of the Better Business Bureau regarding the accuracy of an Instagram post that stated, Ready to say goodbye to hot flashes, weight gain, insomnia and mood swings